ClinicalTrials.Veeva

Menu
E

EAP Osona Sud-Alt Congost SLP | CAP Centelles

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

MK-4482
Molnupiravir
MK-4482-002

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 11 total trials

Efficacy Against Oral Persistent Infection, Immunogenicity and Safety of the 9-valent Human Papillomavirus Vaccine (9vHPV) in Men Aged 20-45 Years (V503-049)

The purpose of this study is to evaluate the efficacy, immunogenicity and safety of the 9vHPV vaccine in men 20 to 45 years of age. The primary hypot...

Active, not recruiting
Papillomavirus Infections
Biological: 9vHPV Vaccine
Other: Placebo (Saline for Injection)

This is a Phase IIb, open-label, uncontrolled, multi-centre, non-inferiority clinical trial, to assess the safety and immunogenicity of BIMERVAX® as...

Enrolling
SARS CoV 2 Infection
Biological: BIMERVAX

Trial sponsors

Merck Sharp & Dohme (MSD) logo
H
Pfizer logo
F

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems